Bionano announces preliminary 3q 2024 revenues and cash

San diego, oct. 10, 2024 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced select preliminary results for the quarter ended september 30, 2024. the company now expects revenue for the third quarter of 2024 to be between $6.5 and $6.8 million, down from prior guidance of between $7.9 and $8.9 million.
BNGO Ratings Summary
BNGO Quant Ranking